Biosynex SA
PAR:ALBIO

Watchlist Manager
Biosynex SA Logo
Biosynex SA
PAR:ALBIO
Watchlist
Price: 2.9 EUR -3.17% Market Closed
Market Cap: 31.2m EUR
Have any thoughts about
Biosynex SA?
Write Note

Biosynex SA
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biosynex SA
Cash & Cash Equivalents Peer Comparison

Comparables:
EDAP
BIM
ALCAR
ALVMG
AMPLI

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Biosynex SA
PAR:ALBIO
Cash & Cash Equivalents
€20.2m
CAGR 3-Years
-18%
CAGR 5-Years
60%
CAGR 10-Years
26%
Edap Tms SA
NASDAQ:EDAP
Cash & Cash Equivalents
€43.5m
CAGR 3-Years
21%
CAGR 5-Years
17%
CAGR 10-Years
21%
Biomerieux SA
PAR:BIM
Cash & Cash Equivalents
€272.2m
CAGR 3-Years
-18%
CAGR 5-Years
2%
CAGR 10-Years
11%
Carmat SA
PAR:ALCAR
Cash & Cash Equivalents
€11.4m
CAGR 3-Years
-42%
CAGR 5-Years
-6%
CAGR 10-Years
4%
Visiomed Group SA
PAR:ALVMG
Cash & Cash Equivalents
€3m
CAGR 3-Years
54%
CAGR 5-Years
36%
CAGR 10-Years
11%
Amplitude Surgical SA
PAR:AMPLI
Cash & Cash Equivalents
€31.3m
CAGR 3-Years
-5%
CAGR 5-Years
12%
CAGR 10-Years
N/A

See Also

What is Biosynex SA's Cash & Cash Equivalents?
Cash & Cash Equivalents
20.2m EUR

Based on the financial report for Dec 31, 2023, Biosynex SA's Cash & Cash Equivalents amounts to 20.2m EUR.

What is Biosynex SA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
26%

Over the last year, the Cash & Cash Equivalents growth was -77%. The average annual Cash & Cash Equivalents growth rates for Biosynex SA have been -18% over the past three years , 60% over the past five years , and 26% over the past ten years .

Back to Top